ACP
ARTV

Acuta Capital Partners’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Acuta Capital Partners’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$68.6K Hold
45,456
– – 0.1% 27
2025
Q1 		$136K Buy
45,456
+1,456
+3% +$4.37K 0.16% 32
2024
Q4 		$444K Hold
44,000
– – 0.45% 34
2024
Q3 		$680K Buy
+44,000
New +$680K 0.55% 32